(The
following is an introduction to a brand profile. The full profile
contains in-depth discussion of spending patters accompanied by three tables of brand
resource data and eight data charts.)
Brand 6 faced some unique
challenges as it entered a market with virtually no direct competitors.
Although this lack of competition was an advantage in some regards, it
also meant that the company had to invest significant resources and time
to increase market awareness of the product and the condition it treats.
To reach the drug’s peak projected annual sales of $250 to $500 million,
Brand 6’s developer will have to continue to devote targeted resources
to overcome gaps in physician knowledge.
As a specialized pharmaceutical, the drug offers physicians a unique
way to treat Brand 6’s intended patients. Although the drug is not a
first-line therapy, it is often used in conjunction with other
treatments to have the greatest effect.
The brand had to create a market for itself, as specialists were
unfamiliar with treating this disease state. The developer relied on its
sales force and detail aids to help effectively commercialize the brand.
In fact, in the first three years the developer drew on a $x million
to develop, manufacture and distribute detailing materials.
In addition to an immature market, Brand 6 also suffered from its
developer’s marketing inexperience. With no other competitors to
benchmark, Brand 6’s team developed its own forecasts and strategies.
Brand 6’s developer was small and relatively inexperienced, and the
drug was the company’s flagship product. It received considerable
attention and financial support, since the developer knew its future
depended on Brand 6’s success. After the brand’s first year on the
market, however, the company was acquired by a big pharma company that
now runs the smaller company as a subsidiary. This development affected
the company’s structure and the resources allocated to Brand 6's marketing
efforts.
Commercial Priorities and Challenges
One of the greatest challenges Brand 6’s team had to overcome was the
lack of a market for the drug. The product addressed a distinct unmet
need, but specialists were not aware of the drug, nor were they used to
treating this disease with a prescription pharmaceutical. To address this challenge,
the brand team focused its promotion on market awareness and education
for both patients and the medical community.
The company, for example, met with several medical schools to
help inform students and physicians about this new treatment option. By going to the
source of medical education, the company hopes
to expand the future market for its product.
The brand team also addressed specialists' unfamiliarity with
pharmaceuticals designed for the condition in question. Though Brand 6’s
developer had to blaze its own trail in this area, the lack of direct
competition allowed the company to establish itself as a leading
provider in this marketplace. Fortunately, targeted specialists are not as
overwhelmed as other physicians because few sales reps call on them.
This fact gives Brand 6’s reps more time with their sales targets...